Aldeyra The (ALDX) vs OKYO Pharma Limited (OKYO)
A side-by-side comparison of Aldeyra The and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OKYO
OKYO Pharma Limited
$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALDX vs OKYO
growth of $100 · dividends reinvested · last 4yALDX -63.1% (-22.0%/yr)OKYO -59.4% (-20.2%/yr)OKYO compounded faster over this window
ALDX OKYO
ALDX vs OKYO: by the numbers
- •OKYO is the larger company ($56M vs $55M market cap).
Metrics side by side
Valuation
| Metric | ALDX | OKYO |
|---|---|---|
| P/B ratio | 1.46 | 4.54 |
Profitability
| Metric | ALDX | OKYO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -60.85% | -72.55% |
| ROIC | -63.52% | -68.91% |
Growth (annualized)
| Metric | ALDX | OKYO |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.